{"_id":"@platforma-open/milaboratories.antibody-sequence-liabilities","_rev":"58-68699399bed10f560005fad02b57a9ed","name":"@platforma-open/milaboratories.antibody-sequence-liabilities","dist-tags":{"latest":"5.5.0"},"versions":{"1.0.0":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"1.0.0","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@1.0.0","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"69e42ef25fad5cc492f38c6056b476229e23a2c9","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-1.0.0.tgz","fileCount":1,"integrity":"sha512-OpFlf/9stHSRJ7t+qr4VfjIl/A7SRXMRRtOPXSpGAEfW37nDQfrET1+SR8bmLUkYt5qW66en2V23b6PZL17dXw==","signatures":[{"sig":"MEUCIQDATUrNwm1wdhn4rszhrGow1ImsYi6Fi9aP5WxAIwdlEgIgNSti5u3TCwc/yKSwsfk9X2s1/LtBwOwv9SDVSlThtOg=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":631},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-1.0.0.tgz","scripts":{"test":"PL_PKG_DEV=local turbo run test --concurrency 1","build":"turbo run build","watch":"turbo watch build","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","build:dev":"PL_PKG_DEV=local turbo run build","changeset":"changeset","mark-stable":"turbo run mark-stable","version-packages":"changeset version"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/b22514b29b6bd1fd26323e4aad2c4a16/platforma-open-milaboratories.antibody-sequence-liabilities-1.0.0.tgz","_integrity":"sha512-OpFlf/9stHSRJ7t+qr4VfjIl/A7SRXMRRtOPXSpGAEfW37nDQfrET1+SR8bmLUkYt5qW66en2V23b6PZL17dXw==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.0","_hasShrinkwrap":false,"devDependencies":{"turbo":"^2.2.3","@changesets/cli":"^2.28.1"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_1.0.0_1744893935668_0.0063353141249218314","host":"s3://npm-registry-packages-npm-production"}},"2.1.0":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.1.0","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.1.0","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"299955dad6dd7a41a7b17c3d75f11481e74864d7","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.1.0.tgz","fileCount":1,"integrity":"sha512-NYCM9GzBmQuMs9XVJgtczSzjsGQDMJWdaVdJlk2Hf0puTCoRaZOIie8iGmwSfMEjmHByfR6M4mT/mm/vjoK8wQ==","signatures":[{"sig":"MEQCIBuFUYharaGhIvhaKPUC3gnVfXw7toZij7oUjMLV8+qzAiAKh9ZtlwU28vDNUUuy7yWzwhkyECHUPVqyoW5UhYcfeA==","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1866},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.1.0.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["tutorial"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md"},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/fd23d2de1b682cbfd92431a8849ad924/platforma-open-milaboratories.antibody-sequence-liabilities-2.1.0.tgz","_integrity":"sha512-NYCM9GzBmQuMs9XVJgtczSzjsGQDMJWdaVdJlk2Hf0puTCoRaZOIie8iGmwSfMEjmHByfR6M4mT/mm/vjoK8wQ==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.0","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"2.0.0","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"2.0.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"2.0.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.5.38"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.1.0_1744893959487_0.729026276532381","host":"s3://npm-registry-packages-npm-production"}},"2.2.0":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.2.0","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.2.0","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"c395ec16094b8dcc2a0ea88085bd88d12881f31b","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.2.0.tgz","fileCount":1,"integrity":"sha512-G/KH0OTuZzXwhRLnfvzZHmE3fxtMS7cVHE9iAoRO4iYrRqmMJHr8oDAzJ86I+fegnTC0X8U7TuvobKmTlZbZaw==","signatures":[{"sig":"MEUCIE/Ugt7ukCsV4VxZ7Jo3ut3krnVF8ZRJx2/tJTdEEIiwAiEA3EKUcYBPWq5XD3+z5CyaVW98Z5H0yz5p89elvKFeda8=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1866},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.2.0.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["tutorial"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md"},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/12e33b77e05c26ac3c25ba7dcea035b5/platforma-open-milaboratories.antibody-sequence-liabilities-2.2.0.tgz","_integrity":"sha512-G/KH0OTuZzXwhRLnfvzZHmE3fxtMS7cVHE9iAoRO4iYrRqmMJHr8oDAzJ86I+fegnTC0X8U7TuvobKmTlZbZaw==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.1","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"2.1.0","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"2.1.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"2.1.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.5.38"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.2.0_1746193502930_0.5928786551357457","host":"s3://npm-registry-packages-npm-production"}},"2.3.0":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.3.0","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.3.0","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"db36bc4c678f8017f827d9f72806dc80599d1456","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.3.0.tgz","fileCount":1,"integrity":"sha512-DHKjxk0iwLkzbar+ae5Kj35jJbWlfaSc+RVecsDW5+CynX3T7j2P5cpCWX/Fvm/T/1mpEhmqwwKpIfijYktYYA==","signatures":[{"sig":"MEUCIQDVAdbUCS/nDSUg/rKb9m0kzS6XR+JKdpcs3t0gEDsw+QIgJumVLTxi7aK9zg7299yY6wkYKGtYLpWd64EOxi0DYgA=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.3.0.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/c5a6f783ef59874bd834e566f9a0ac64/platforma-open-milaboratories.antibody-sequence-liabilities-2.3.0.tgz","_integrity":"sha512-DHKjxk0iwLkzbar+ae5Kj35jJbWlfaSc+RVecsDW5+CynX3T7j2P5cpCWX/Fvm/T/1mpEhmqwwKpIfijYktYYA==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.1","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.0.0","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.0.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.0.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.5.47"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.3.0_1747484600406_0.31833216728314717","host":"s3://npm-registry-packages-npm-production"}},"2.3.1":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.3.1","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.3.1","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"262279a58f79e715b074cf0692fdadb086aaf24a","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.3.1.tgz","fileCount":1,"integrity":"sha512-/nQ0jtclkFnbQMp9GrRckvZxk4q4sNjNcjqwZv1syVUxEPKN4xUfHEnVCbP4cOafltvVpwB05/PS2mg1Mqw7fg==","signatures":[{"sig":"MEUCIQCbhiJq9A0YxLonFQF6eeFCasH0ZIJp1x9XxbzeDGavVQIgaSEkNgx7J5qbHGrm+LRa0Pwjb0JBujNFhiCnad+AqrM=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.3.1.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/a9145c85ead779db357d15d9e7dc4ef9/platforma-open-milaboratories.antibody-sequence-liabilities-2.3.1.tgz","_integrity":"sha512-/nQ0jtclkFnbQMp9GrRckvZxk4q4sNjNcjqwZv1syVUxEPKN4xUfHEnVCbP4cOafltvVpwB05/PS2mg1Mqw7fg==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.1","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.0.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.5.47"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.3.1_1747646517990_0.007168399962108385","host":"s3://npm-registry-packages-npm-production"}},"2.3.2":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.3.2","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.3.2","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"a007a280070b98e730f7bfa71176aef2af259edb","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.3.2.tgz","fileCount":1,"integrity":"sha512-ohSqd6lmlYROU+Klt1qiCh4NM1rxqav0O1Mm1fnmFZzzzZwfgYn1g+4ATPe9wFMOCcq2tMicacixbLo5TJoing==","signatures":[{"sig":"MEYCIQCHdfnc5KFZ6m4Cz/7i/H/33mF3NY82mwt58rMnlMSzxQIhALxerMQdCQmihXQUJuHyfVK4VKnoulYHKAvJ+VeBmb3X","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.3.2.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/e462d1e2e11b2f3d2dee67d30ad84687/platforma-open-milaboratories.antibody-sequence-liabilities-2.3.2.tgz","_integrity":"sha512-ohSqd6lmlYROU+Klt1qiCh4NM1rxqav0O1Mm1fnmFZzzzZwfgYn1g+4ATPe9wFMOCcq2tMicacixbLo5TJoing==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.1.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.5.47"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.3.2_1749639080677_0.058548204927246994","host":"s3://npm-registry-packages-npm-production"}},"2.3.3":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.3.3","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.3.3","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"beb85a0822db5b840e6ece70d1703fb8d96a6ff8","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.3.3.tgz","fileCount":1,"integrity":"sha512-UZpBqZ7ympF0mh1aWjgdNzXakyJUHLVTvRb460cm+yc+H1IfF/HdWYOxHoy2xYboFyiGlOlh3eFoKX4r59J2uw==","signatures":[{"sig":"MEUCIQDQYt49eBUWU5F7xut4hcsjsDSWKlHcjAMD0JJjfCzXFAIgax046xIvIVe4e3KP+XTfxntQrhlsa4XlFtquIgE70WQ=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.3.3.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/eb4d832496431b60cdfa52b0ca595ae6/platforma-open-milaboratories.antibody-sequence-liabilities-2.3.3.tgz","_integrity":"sha512-UZpBqZ7ympF0mh1aWjgdNzXakyJUHLVTvRb460cm+yc+H1IfF/HdWYOxHoy2xYboFyiGlOlh3eFoKX4r59J2uw==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.1.1"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.5.52"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.3.3_1749654965732_0.6222979277856082","host":"s3://npm-registry-packages-npm-production"}},"2.3.4":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.3.4","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.3.4","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"234266289c1f7d6e3274163386b639949ca7013d","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.3.4.tgz","fileCount":1,"integrity":"sha512-JZ3PNGIHPVWucWWz/e3Jgg3r9hQ1rnQLbQQZBB6RWXX36A07NURN8mqdTMjGVYaAcqfvq2iNc1MsbXT8GgOMaw==","signatures":[{"sig":"MEUCIQD19NbmtlVj8DeGVxvHRy7M8qWMwpOzIGLs8xaJFcbNFwIgA8e1/GG1XDv9zQIlnKr4Mauz2L1AWL8rPIGTrlCZVSo=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.3.4.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/12c20a3743cbfc5fdfe285bc7f6cca56/platforma-open-milaboratories.antibody-sequence-liabilities-2.3.4.tgz","_integrity":"sha512-JZ3PNGIHPVWucWWz/e3Jgg3r9hQ1rnQLbQQZBB6RWXX36A07NURN8mqdTMjGVYaAcqfvq2iNc1MsbXT8GgOMaw==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.1.1"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.5.52"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.3.4_1749729278653_0.7572149759656996","host":"s3://npm-registry-packages-npm-production"}},"2.3.5":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.3.5","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.3.5","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"0c9f1274d74b0ed04b82682cbe59101f9e265c3b","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.3.5.tgz","fileCount":1,"integrity":"sha512-HsQBeER+bl6ujcJIzER6n4ezlwbWhh3Bxtob7jDPFNRNFptThXnobZwkA0TQlt72yMuHthNugLV4JFKcEmjKsw==","signatures":[{"sig":"MEUCIHIwpGAcCcDtpJuld+heRnr5gkDLuPWzgzRvueNgyxkkAiEAxXGtKWwMF56Kyj3nktaRwKfnZyJLAhG+xCINZpELxOI=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.3.5.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","actor":{"name":"dbolotin_mi","type":"user","email":"bolotin@milaboratories.com"},"email":"bolotin@milaboratories.com"},"_resolved":"/tmp/46ac086eba2473d02319a9ee665ef3a3/platforma-open-milaboratories.antibody-sequence-liabilities-2.3.5.tgz","_integrity":"sha512-HsQBeER+bl6ujcJIzER6n4ezlwbWhh3Bxtob7jDPFNRNFptThXnobZwkA0TQlt72yMuHthNugLV4JFKcEmjKsw==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.0.2","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.0.2","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.1.2"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.5.54"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.3.5_1750253544192_0.7455906824857932","host":"s3://npm-registry-packages-npm-production"}},"2.3.6":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.3.6","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.3.6","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"9b707c2435330bf8ae2d83d253c343e46ca29a4f","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.3.6.tgz","fileCount":1,"integrity":"sha512-0yVRMbnEOksU2dvst3T387JdD0zp8FY2V2nkhPOOH97qrrVGYkK6fut4MwRs+sAfrelMsqkvwFy7sH/pnxy7Ww==","signatures":[{"sig":"MEUCIBgn/G08Vs7aVABZC4hAs5k26pPqDvL/LVhoXDCZbHR+AiEAxmCCCj1WiyJhry7aQhqzFce76Fjyj3V6t1xP/6HfSwQ=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.3.6.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","actor":{"name":"dbolotin_mi","type":"user","email":"bolotin@milaboratories.com"},"email":"bolotin@milaboratories.com"},"_resolved":"/tmp/4faa1533e556c2b66f7160c817503a97/platforma-open-milaboratories.antibody-sequence-liabilities-2.3.6.tgz","_integrity":"sha512-0yVRMbnEOksU2dvst3T387JdD0zp8FY2V2nkhPOOH97qrrVGYkK6fut4MwRs+sAfrelMsqkvwFy7sH/pnxy7Ww==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.1.2"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.5.59"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.3.6_1750975196722_0.8593813296368085","host":"s3://npm-registry-packages-npm-production"}},"2.4.0":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.4.0","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.4.0","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"a4864d58146d2d442f7492d339ba16e7f1f05551","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.4.0.tgz","fileCount":1,"integrity":"sha512-20PjGYRqa95aztYkyNEYabTOJEy+by52cl1rSh6RRDB3xEOT4MmwS0S3kHz90aMkijx2RFIA/0onqJwU2tDlVA==","signatures":[{"sig":"MEUCIQDK0EtDJbLfISkFCqrsrCibIPZZAs3tDY0apWAcHO8sawIgAKpL7CQYzA6lnKF0wQjWYEpSInKJdo0c4r+PW4y2+48=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.4.0.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","actor":{"name":"dbolotin_mi","type":"user","email":"bolotin@milaboratories.com"},"email":"bolotin@milaboratories.com"},"_resolved":"/tmp/52a93726755245ca436b376cdfe0db24/platforma-open-milaboratories.antibody-sequence-liabilities-2.4.0.tgz","_integrity":"sha512-20PjGYRqa95aztYkyNEYabTOJEy+by52cl1rSh6RRDB3xEOT4MmwS0S3kHz90aMkijx2RFIA/0onqJwU2tDlVA==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.1.2"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.5.59"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.4.0_1751387386824_0.45468166977985125","host":"s3://npm-registry-packages-npm-production"}},"2.4.1":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.4.1","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.4.1","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"42fe36010b6f4a18b2f82e6044218e5be0fd0363","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.4.1.tgz","fileCount":1,"integrity":"sha512-V0jVcIys4EO30yctQ69MaCl4nKJbrhz4ho1Bmfy0xe2hGTfA44TCLWZ0pjIiktUNP2SASrg4byPc04HD+tkgKw==","signatures":[{"sig":"MEUCIHRO0XjWnyvsm3wIzdQWJA+28TX41bQvJFSKBsdJuc7+AiEAs7YphHEB1QRxYorpUJ7ASe2pr3OpFOWjugGN5YMY4E4=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.4.1.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","actor":{"name":"dbolotin_mi","type":"user","email":"bolotin@milaboratories.com"},"email":"bolotin@milaboratories.com"},"_resolved":"/tmp/ea2a169fb7ea8a82adf82dc1bcd8e460/platforma-open-milaboratories.antibody-sequence-liabilities-2.4.1.tgz","_integrity":"sha512-V0jVcIys4EO30yctQ69MaCl4nKJbrhz4ho1Bmfy0xe2hGTfA44TCLWZ0pjIiktUNP2SASrg4byPc04HD+tkgKw==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.3","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.2.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.5.61"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.4.1_1751817731188_0.6634348849214404","host":"s3://npm-registry-packages-npm-production"}},"2.4.2":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.4.2","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.4.2","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"459e55a8a888b2ca3b5a393609af13565921a5c4","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.4.2.tgz","fileCount":1,"integrity":"sha512-6WzObXh3LIbMa0sVIAYimyRrNb/6lawKIFkpDTT0B6llHGWl80d5i/rjKr3eBr8h7ZJs3qjQ/xjrS+ZAfogVnw==","signatures":[{"sig":"MEUCIQCBVfCOep1bjMmfvdKfuAQg4fl7JO+xIcbzFpAOSaqiqAIgWfOehCIzag4MXxxK0yjeMrVQOB96uOBHlNy0i3D7n5w=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.4.2.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","actor":{"name":"dbolotin_mi","type":"user","email":"bolotin@milaboratories.com"},"email":"bolotin@milaboratories.com"},"_resolved":"/tmp/0cda35ac9d4611cd35092c09474433af/platforma-open-milaboratories.antibody-sequence-liabilities-2.4.2.tgz","_integrity":"sha512-6WzObXh3LIbMa0sVIAYimyRrNb/6lawKIFkpDTT0B6llHGWl80d5i/rjKr3eBr8h7ZJs3qjQ/xjrS+ZAfogVnw==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.3","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.3.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.5.61"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.4.2_1751894194174_0.6013789103439637","host":"s3://npm-registry-packages-npm-production"}},"2.4.3":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.4.3","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.4.3","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"9b13582da183e1d2d5a9440d4db9351013f4f853","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.4.3.tgz","fileCount":1,"integrity":"sha512-6tokmChZIo2E+rJHGC6AnbpWohliQA8hJPh13FySD9ZC6mHa/ztObVIxRdx9OyLDPr+ZrIkUeKS0AGmEJKM8zA==","signatures":[{"sig":"MEUCIQDm09MToRCHYdK2aqFeQ4QDjdaONdP2kXEmMTU9X/bQVwIgbAGO03ETeQxkdSS9lIE1khxOGGObIL+9eGms85/cpF8=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.4.3.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/e2ade6e637849b79ce0c58daf635ca79/platforma-open-milaboratories.antibody-sequence-liabilities-2.4.3.tgz","_integrity":"sha512-6tokmChZIo2E+rJHGC6AnbpWohliQA8hJPh13FySD9ZC6mHa/ztObVIxRdx9OyLDPr+ZrIkUeKS0AGmEJKM8zA==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.4","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.3.1"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.5.61"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.4.3_1753279196810_0.35179813372254","host":"s3://npm-registry-packages-npm-production"}},"2.4.4":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.4.4","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.4.4","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"907c77d2cefb6ececc454f77bd6eeffa4b5639af","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.4.4.tgz","fileCount":1,"integrity":"sha512-61+dluoi+DQBU1lUMg7cUdUiemwgvVUnbilJb+Y2B8hLI0G9OVgBDi3hpae4m3Qm96JijUP6590AOP3zWDEr9g==","signatures":[{"sig":"MEUCIAKLaUWhj8r6MLTujLO9/thvVXX6OvfvrwR0M8VlTC41AiEAnQYo/ylpPBmbCkVV1Y9xMUJv0yF7R/0abuZQxFv1InI=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.4.4.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/102469cb23b81f5009bb48e7c60613cf/platforma-open-milaboratories.antibody-sequence-liabilities-2.4.4.tgz","_integrity":"sha512-61+dluoi+DQBU1lUMg7cUdUiemwgvVUnbilJb+Y2B8hLI0G9OVgBDi3hpae4m3Qm96JijUP6590AOP3zWDEr9g==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.4","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.4.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.5.61"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.4.4_1754393650389_0.06982015131105723","host":"s3://npm-registry-packages-npm-production"}},"2.4.5":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.4.5","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.4.5","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"8618b26ad2df56b356309edca8db693efaab4e7b","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.4.5.tgz","fileCount":1,"integrity":"sha512-tUp8pC79pXJEaWt1mFdy51vxAf17aam2lGg1pD2AkdUJfUaBNEK/oH5FdJFyv7fTqyYEfMdi9S79KUS2Npx9mw==","signatures":[{"sig":"MEUCIQCPH13CfNQmMa5GenV9a14NArnGGrXa/tqE31707r+bQwIgEjbIFbriXhHDr0tIYUebd8M1d/hIiprY/oYMK+wH4aQ=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.4.5.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/2d1338d5a70b0f875d701dfc6e9b57c2/platforma-open-milaboratories.antibody-sequence-liabilities-2.4.5.tgz","_integrity":"sha512-tUp8pC79pXJEaWt1mFdy51vxAf17aam2lGg1pD2AkdUJfUaBNEK/oH5FdJFyv7fTqyYEfMdi9S79KUS2Npx9mw==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.4","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.1.0","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.1.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.4.1"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.5.76"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.4.5_1754637754429_0.8518815542470117","host":"s3://npm-registry-packages-npm-production"}},"2.4.6":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.4.6","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.4.6","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"ee34031a388e30ce2eebccb9d557decc4251cbee","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.4.6.tgz","fileCount":1,"integrity":"sha512-FLDhj9QXTdP/CzEOfqvJM7QX1Kumyimtdj9wXwOKmBq9Up3Dpc1UOJ0QsNy9jzOT/4hNBfcYWnMrQYL93mqCsQ==","signatures":[{"sig":"MEQCIBqb2USlKu0/ZgWdFinUCpSePf3HovUcypWUYxiZKhGxAiB2d3N1Tf8D9QdpMBYnVOU34vaI1+Km0FiknEC84tnKoA==","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.4.6.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/ab6460d4894d0857e522ab281f193ec7/platforma-open-milaboratories.antibody-sequence-liabilities-2.4.6.tgz","_integrity":"sha512-FLDhj9QXTdP/CzEOfqvJM7QX1Kumyimtdj9wXwOKmBq9Up3Dpc1UOJ0QsNy9jzOT/4hNBfcYWnMrQYL93mqCsQ==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.4","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.1.0","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.1.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.4.2"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.5.83"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.4.6_1754656168444_0.9962853910241913","host":"s3://npm-registry-packages-npm-production"}},"2.4.7":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.4.7","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.4.7","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"61668d69b2de0fefa61252df1511cc5133c358cf","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.4.7.tgz","fileCount":1,"integrity":"sha512-BCqMV0v4v/7URz39i0BxGb0l1x+eTrs6C9OAU/ZObCNlt5/YqA5vrR6V+60Z5zxe/iZ8reWlRSTdH+Zowas/Fg==","signatures":[{"sig":"MEQCIAruUcyj2W/uBloHFpsAoTkv6nAOQ+zlZrr8ZD+xQFSJAiAn96qZcGoxMSl5Eb0J8kaEZ6MIKZDUNUrPlJzBJfB/Mg==","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.4.7.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/c3b8c9141c301830d4ce3dab8647aaa2/platforma-open-milaboratories.antibody-sequence-liabilities-2.4.7.tgz","_integrity":"sha512-BCqMV0v4v/7URz39i0BxGb0l1x+eTrs6C9OAU/ZObCNlt5/YqA5vrR6V+60Z5zxe/iZ8reWlRSTdH+Zowas/Fg==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.4","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.1.0","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.1.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.4.3"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.5.83"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.4.7_1754905863496_0.7780327242353353","host":"s3://npm-registry-packages-npm-production"}},"2.4.9":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.4.9","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.4.9","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"3645d03b463061d7e528cc37afb1c4f0e0a59de2","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.4.9.tgz","fileCount":1,"integrity":"sha512-IOB6GzaDWsOxo9JgOgw1M+drvoiH06pZ+7/isr0Kd+B7Rjt4EME9uga+uTQVyZYj6olb94YSYYkqeW/t5z70mg==","signatures":[{"sig":"MEYCIQCzGxpfJNDsz+kert2j8SLR4oevP0oSW7iQlLurOI7QlwIhAJd5qKC6fd/S0cweDu0Oh1ixKTRQvpGHoWEQgg2oLYNO","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1938},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.4.9.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/7e770938cbae96ad5057120f98fa41a9/platforma-open-milaboratories.antibody-sequence-liabilities-2.4.9.tgz","_integrity":"sha512-IOB6GzaDWsOxo9JgOgw1M+drvoiH06pZ+7/isr0Kd+B7Rjt4EME9uga+uTQVyZYj6olb94YSYYkqeW/t5z70mg==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.5","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.1.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.1.1","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.4.5"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.6.4"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.4.9_1758111739852_0.6959203531356963","host":"s3://npm-registry-packages-npm-production"}},"2.4.10":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.4.10","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.4.10","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"55b59963c6a1f2feb13806a4674c008ea6e2b88b","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.4.10.tgz","fileCount":1,"integrity":"sha512-TwMDmkZegbLomb5dk2VqguoSKD6IZ+pPJYOUsMIKx1eDl2nOJ+pjvxQvo8k4OQ4BGL0TC2Vpnfg5J30HqF37pA==","signatures":[{"sig":"MEYCIQCD32quksTL7VUsQkQAfvGUTEE+mrX/lGs2NADWmWzKMQIhAMCwkjw8E59F6lyMbOuyjEPHOGYyLjSmJEoQ8mQG+h9/","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.4.10.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/82e2634500848cd06ceffa2cfde3605d/platforma-open-milaboratories.antibody-sequence-liabilities-2.4.10.tgz","_integrity":"sha512-TwMDmkZegbLomb5dk2VqguoSKD6IZ+pPJYOUsMIKx1eDl2nOJ+pjvxQvo8k4OQ4BGL0TC2Vpnfg5J30HqF37pA==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.5","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.1.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.1.1","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.4.6"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.6.4"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.4.10_1758701917822_0.09845217049906507","host":"s3://npm-registry-packages-npm-production"}},"2.4.11":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.4.11","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.4.11","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"60c93d4d8f011d9e21a061ea9079655a6aa0df34","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.4.11.tgz","fileCount":1,"integrity":"sha512-TBo4HteLoj6DHBh0sZYYJC3Wb7S+HcUwT0fbsxfD+pCkJTZRnNP2GH/6k3zOz0Zd72Xhoa5UzqTA/GoAR5g1sA==","signatures":[{"sig":"MEUCIGshST1xm8MwFsVVIw5mmnA50hdj31cblYjVg2HoW4HcAiEAs5rmZNvI6FVzWh5WjclfaaWsaW0QVABKwOi8JB8RvaQ=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.4.11.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/42d98c0dfdcdc79ca6af876aff658aab/platforma-open-milaboratories.antibody-sequence-liabilities-2.4.11.tgz","_integrity":"sha512-TBo4HteLoj6DHBh0sZYYJC3Wb7S+HcUwT0fbsxfD+pCkJTZRnNP2GH/6k3zOz0Zd72Xhoa5UzqTA/GoAR5g1sA==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.5","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.1.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.1.1","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.4.7"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.6.4"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.4.11_1758810009858_0.8512375220209514","host":"s3://npm-registry-packages-npm-production"}},"2.4.12":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.4.12","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.4.12","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"35246016f0c8f959733b7fd10f0af2fe7b3bbb15","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.4.12.tgz","fileCount":1,"integrity":"sha512-5qIuBBgBeqUjouELPGY25kTktcjwMfPBiT5yXZknG0uKcpi9MZgSGNIh1fPxfH+6esmWqifes6euN6hqd4EMFQ==","signatures":[{"sig":"MEYCIQDysme90dGaWkFdRHmgmSYTykOXJZ6T5PQA5ajSv6lcNwIhAPxWxSz0HPlLgkHuja+zAnRQU47HgDYy7sqIMUdn0b6O","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.4.12.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/1f58e4aeda665199fa8fa4355a81b17b/platforma-open-milaboratories.antibody-sequence-liabilities-2.4.12.tgz","_integrity":"sha512-5qIuBBgBeqUjouELPGY25kTktcjwMfPBiT5yXZknG0uKcpi9MZgSGNIh1fPxfH+6esmWqifes6euN6hqd4EMFQ==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.5","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.1.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.1.1","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.4.8"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.6.4"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.4.12_1759313885942_0.07305864935178041","host":"s3://npm-registry-packages-npm-production"}},"2.4.13":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.4.13","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.4.13","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"2d78666624f4d2d67ebe848ddf0840c126f5358c","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.4.13.tgz","fileCount":1,"integrity":"sha512-VvTQ9A0Z91rjdwz8/VDRmXyuFGfARmEyy0fJ1UqI4GbZpqaGRtlnjMMXmp/wL1R8Dbt8iJQQXLcMb8QsmQiOHQ==","signatures":[{"sig":"MEUCIQCmM8fNWHvtJStyEVQRP4My+z9tiNhRThpTe1L0eVJJUwIgTbbQd1kQB/tVqpn2a8WYTpAyRQCk+M8ShyK71ofhBMw=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.4.13.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/2ad2c45c602aec5caeef9323244612ae/platforma-open-milaboratories.antibody-sequence-liabilities-2.4.13.tgz","_integrity":"sha512-VvTQ9A0Z91rjdwz8/VDRmXyuFGfARmEyy0fJ1UqI4GbZpqaGRtlnjMMXmp/wL1R8Dbt8iJQQXLcMb8QsmQiOHQ==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.5","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.1.2","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.1.1","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.4.8"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.6.4"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.4.13_1759316066182_0.8318360698290586","host":"s3://npm-registry-packages-npm-production"}},"2.4.14":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.4.14","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.4.14","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"9622876117529c8d37134b97a767b5d5554ae432","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.4.14.tgz","fileCount":1,"integrity":"sha512-LV4TGFpjBQApxJGnQYPgZTqu3MzDxVYe6kRTEjjg3vWxrhrWJUM0OfOBGdhwm8qM59mB3CR0JdpUSBeYIqQGMg==","signatures":[{"sig":"MEUCIQCjhEtw4uSvZnqKCNCISBQ7QL7BNg6Xaf7CBC6S9Sza/gIgIstAoLrNlejV1xOMgJjYaK8yN9OfLlCof8+Q674KH1o=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1939},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.4.14.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/2ed7be59661f7fbf226eb986e168a4ec/platforma-open-milaboratories.antibody-sequence-liabilities-2.4.14.tgz","_integrity":"sha512-LV4TGFpjBQApxJGnQYPgZTqu3MzDxVYe6kRTEjjg3vWxrhrWJUM0OfOBGdhwm8qM59mB3CR0JdpUSBeYIqQGMg==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.5","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.1.3","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.1.2","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.4.9"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.6.4"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.4.14_1760476037337_0.4648411378328756","host":"s3://npm-registry-packages-npm-production"}},"2.4.15":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.4.15","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.4.15","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"d90276fd3366124685e051c8ddabc20af7ba280d","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.4.15.tgz","fileCount":1,"integrity":"sha512-F8Ln6Y5yjzoT4e94qWv7OT9NXMh4Y3qiLFkEEa/hMjyb6A6fU80UFMrLM5Qb3A0VAvNHfg+OJWWwI5rIWVjLsA==","signatures":[{"sig":"MEYCIQDRQDO3xN5JArg9tH2i9HEXYS2zKOSviTcpDt6priGSpQIhAPV7K6frovF1DevgiWiUZjaqsuF6Yu9A9vEA365coWUB","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1941},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.4.15.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/e5f4d4d9d361c0295540ca1498f54e37/platforma-open-milaboratories.antibody-sequence-liabilities-2.4.15.tgz","_integrity":"sha512-F8Ln6Y5yjzoT4e94qWv7OT9NXMh4Y3qiLFkEEa/hMjyb6A6fU80UFMrLM5Qb3A0VAvNHfg+OJWWwI5rIWVjLsA==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.5","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.1.3","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.1.2","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.4.10"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.6.15"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.4.15_1761152469135_0.10329647496949024","host":"s3://npm-registry-packages-npm-production"}},"2.4.16":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.4.16","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.4.16","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"b25c33c0edf94cccf5d4337b702266a9ede6f978","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.4.16.tgz","fileCount":1,"integrity":"sha512-AzhNY8fvmuLgfkxrmGHF6K+aB0RzALwEFP27dF+oHCaXsg1t/t8BWFX1ZcrACPHSqtwt/AeIa+zjMFLWa3CFeg==","signatures":[{"sig":"MEUCIQCNKsstv0Ijwf5qqr2WM0aiH49aJeeMn+RrXgzW8GwTxQIgPLEmfNbr8rKvKIyN5kwJt1PZFwEN9uTDjUhy6oq4H08=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1941},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.4.16.tgz","block":{"meta":{"url":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities","docs":"https://github.com/milaboratory/platforma-antibody-sequence-liabilities/docs","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Calculate sequence liabilities for antibody sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/b3b4753cd3ae074c9f7e1af961048bc8/platforma-open-milaboratories.antibody-sequence-liabilities-2.4.16.tgz","_integrity":"sha512-AzhNY8fvmuLgfkxrmGHF6K+aB0RzALwEFP27dF+oHCaXsg1t/t8BWFX1ZcrACPHSqtwt/AeIa+zjMFLWa3CFeg==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.5","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.1.3","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.1.2","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.4.10"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.6.16"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.4.16_1761842253137_0.5853772991498813","host":"s3://npm-registry-packages-npm-production"}},"2.4.17":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"2.4.17","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@2.4.17","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"302b1f7644f9e16fe14cb2fef3239c93ab7b9e9f","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-2.4.17.tgz","fileCount":1,"integrity":"sha512-JKkhjeg25BmB2AfYcIN+8lt1h7SjF6sOFRJTkIOjBzpWqycqjq6yDuxmbhFYGBfRNDOFwQFoStTEJz0GMT5YXA==","signatures":[{"sig":"MEYCIQC74oEFTbYENgkHKikQfWjiZZkRCO6OR0+B+u5k/WV+8AIhALZPzk/PW8OvWIPhGOLAms4Ugr+leOZynaG2N8dwvgi1","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1987},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-2.4.17.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities in antibody sequences that may impact manufacturability, stability, or safety.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","pretty":"prettier --write \"./**/*.{js,jsx,mjs,cjs,ts,tsx,json,vue}\"","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/70ba15fe0b1f3d5fc100e15215a0f8e4/platforma-open-milaboratories.antibody-sequence-liabilities-2.4.17.tgz","_integrity":"sha512-JKkhjeg25BmB2AfYcIN+8lt1h7SjF6sOFRJTkIOjBzpWqycqjq6yDuxmbhFYGBfRNDOFwQFoStTEJz0GMT5YXA==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.5","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"3.1.3","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"3.1.2","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"3.4.10"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"^2.6.21"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_2.4.17_1763211335993_0.9472340350312483","host":"s3://npm-registry-packages-npm-production"}},"3.0.0":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"3.0.0","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@3.0.0","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"bd0098cc7158f139734a3128a1bf83bdd89d5721","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-3.0.0.tgz","fileCount":1,"integrity":"sha512-VDuUY4aw7jcgriwMiBoBd00nAWwAMF0PPNkKgP1OOjKrW1aatI2/27Y930j2iVNEL+P8vY0OUjeyQKkfPQWyWw==","signatures":[{"sig":"MEUCIE8EKYJ1/FQ/pxUNDtkcJIZU43kJaBJ4hTJbqOGUn/HxAiEAymXWn2CNYqvT23qGMBfJOW6KkxjjWiczG9D0PIdZwl8=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1973},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-3.0.0.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities in antibody sequences that may impact manufacturability, stability, or safety.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","do-pack":"rm -f *.tgz && pnpm pack && mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/1e38b356a7082a137c12e5a599e5a7ef/platforma-open-milaboratories.antibody-sequence-liabilities-3.0.0.tgz","_integrity":"sha512-VDuUY4aw7jcgriwMiBoBd00nAWwAMF0PPNkKgP1OOjKrW1aatI2/27Y930j2iVNEL+P8vY0OUjeyQKkfPQWyWw==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.6","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"4.0.0","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"4.0.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"4.0.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.6.29"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_3.0.0_1767955039516_0.30239860366722415","host":"s3://npm-registry-packages-npm-production"}},"3.0.1":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"3.0.1","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@3.0.1","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"568cbbacc3af93706ebb87a7ac7f60e1af1fd6cd","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-3.0.1.tgz","fileCount":1,"integrity":"sha512-pN77wUiQdMF3mP+505aMhe8xFfr7gOWBzOEvPW+xgRZb2IJx8ClEwNJqwflYpyNSYzotbmRUG0EP+eJT1y3CKw==","signatures":[{"sig":"MEYCIQD3ybQxU7zkGKYlrZa/BPI6KsuL4KyUnxcVt2DIQ7dM6gIhANlnmk2kKcXbpCjNJ7TpkicXsl6aC1Zx+TMMy5mPax2q","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1973},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-3.0.1.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities in antibody sequences that may impact manufacturability, stability, or safety.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","do-pack":"rm -f *.tgz && pnpm pack && mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/8fb30447b7ae7f0c160146e616217d50/platforma-open-milaboratories.antibody-sequence-liabilities-3.0.1.tgz","_integrity":"sha512-pN77wUiQdMF3mP+505aMhe8xFfr7gOWBzOEvPW+xgRZb2IJx8ClEwNJqwflYpyNSYzotbmRUG0EP+eJT1y3CKw==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.6","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"4.1.0","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"4.1.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"4.1.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.6.29"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_3.0.1_1768317547494_0.8473480165409848","host":"s3://npm-registry-packages-npm-production"}},"3.0.2":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"3.0.2","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@3.0.2","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"759d1fbee87dd7a4f46d4e9fd2d1f2268f4c95d2","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-3.0.2.tgz","fileCount":1,"integrity":"sha512-wN6egH2QLX3v4rYNGBM6xboSY6zqHyTHLNhbiSlY2iV/BQrQzOc5xvq7xN+sCvbOPlBFBaUt1xV+tADHVqDM0A==","signatures":[{"sig":"MEYCIQDdVs3M9tgvV4hakCtQsj+LUUf1a0BGKf3CIr/GZ4r3TAIhANgfaN1KGQOJOwqF4YsNimGmeXfoZ+BDtZTMFfQOBPoX","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1973},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-3.0.2.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities in antibody sequences that may impact manufacturability, stability, or safety.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"rm -rf ./block-pack && block-tools pack","do-pack":"rm -f *.tgz && pnpm pack && mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/b11ff2d7e6271d46afc4125cdbb95e86/platforma-open-milaboratories.antibody-sequence-liabilities-3.0.2.tgz","_integrity":"sha512-wN6egH2QLX3v4rYNGBM6xboSY6zqHyTHLNhbiSlY2iV/BQrQzOc5xvq7xN+sCvbOPlBFBaUt1xV+tADHVqDM0A==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.19.6","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"4.1.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"4.1.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"4.1.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.6.29"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_3.0.2_1768915328202_0.9572894269194245","host":"s3://npm-registry-packages-npm-production"}},"3.1.0":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"3.1.0","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@3.1.0","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"fc3931ab06c83a38bdd621992d93a1ec1445f45e","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-3.1.0.tgz","fileCount":1,"integrity":"sha512-e76UDanA7G294PzATkKTE342E9iIKQsegL/mTGgoKFX4iCdlZgLpL4rb1u0CwSAcAZ6l6CnxnfYP6tmINRefzQ==","signatures":[{"sig":"MEYCIQCtCy/ewasNoNaP0aVgFiYM0QKcfECRaSnMCpdLOZLEnQIhAN/Ud9yDtVYQMHMXeIUR/XAzrKF5QEBMmP6H8k106n71","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1985},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-3.1.0.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities in antibody sequences that may impact manufacturability, stability, or safety.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/08350611a90ab8510b356c56a3e83fa8/platforma-open-milaboratories.antibody-sequence-liabilities-3.1.0.tgz","_integrity":"sha512-e76UDanA7G294PzATkKTE342E9iIKQsegL/mTGgoKFX4iCdlZgLpL4rb1u0CwSAcAZ6l6CnxnfYP6tmINRefzQ==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.0","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"4.2.0","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"4.2.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"4.2.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.6.31"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_3.1.0_1769430945027_0.527423715107957","host":"s3://npm-registry-packages-npm-production"}},"3.2.0":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"3.2.0","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@3.2.0","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"392b0da9de8cb5110e5d4934c7c41a6ea6f9dc20","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-3.2.0.tgz","fileCount":1,"integrity":"sha512-guUuig7J8PUZ1DujQbDMJjhNU1QQ/EgdZ5ZGyS9N9fwa1TS/Uv+ZSNUJCfgPeBDO63nccuIuYic1Ix3WRwAzig==","signatures":[{"sig":"MEUCIQCxsNTPCSVQcK3vRWrogLbU7cLC/x4Y0ux20H/6uPLVQQIgSJUkWkdYwZUdw+mIMl8057/C1wANu8OAqdSdrTmQSAI=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1985},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-3.2.0.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities in antibody sequences that may impact manufacturability, stability, or safety.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/cc017975e9f37bf5bc7408309c532707/platforma-open-milaboratories.antibody-sequence-liabilities-3.2.0.tgz","_integrity":"sha512-guUuig7J8PUZ1DujQbDMJjhNU1QQ/EgdZ5ZGyS9N9fwa1TS/Uv+ZSNUJCfgPeBDO63nccuIuYic1Ix3WRwAzig==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.0","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"4.3.0","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"4.3.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"4.3.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.6.35"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_3.2.0_1769686755209_0.30380041275264835","host":"s3://npm-registry-packages-npm-production"}},"3.2.1":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"3.2.1","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@3.2.1","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"3ca68b339e729069cfbc0fe6775bbeacde4cb870","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-3.2.1.tgz","fileCount":1,"integrity":"sha512-jimEgJz2qa7J3Na7se4m/7t52kVwBGRgNBn6rjkLFoeWzFMS5Rjs8wPzEiL+Ffd3qKCZngBEnuntoYxH5gCWNw==","signatures":[{"sig":"MEUCIB07N7qrVg0W/G+MnyFHPaRe4If2MmR6hE0tfeTRfE1PAiEA+p9hesQfUCsNMqVAYAE45/WKnqy4hnM2TWSuTbDVKCI=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1985},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-3.2.1.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities in antibody sequences that may impact manufacturability, stability, or safety.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"},"_resolved":"/tmp/31140c16f0c9b9ebd8b54b54b77f3759/platforma-open-milaboratories.antibody-sequence-liabilities-3.2.1.tgz","_integrity":"sha512-jimEgJz2qa7J3Na7se4m/7t52kVwBGRgNBn6rjkLFoeWzFMS5Rjs8wPzEiL+Ffd3qKCZngBEnuntoYxH5gCWNw==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.0","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"4.3.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"4.3.1","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"4.3.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.6.36"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_3.2.1_1769774221017_0.4527804820987207","host":"s3://npm-registry-packages-npm-production"}},"4.0.0":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"4.0.0","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@4.0.0","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"2601a91239139074b9b3f578e69caad16cbb9f1c","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-4.0.0.tgz","fileCount":1,"integrity":"sha512-VEBQGyLKK4GIfddTAHl/jvFqr0o9iO3eOc4kIa7TyBjGxTRnWvPLTCgB5B1SDDCL303IEouRU+LEeF0p8VVGRg==","signatures":[{"sig":"MEYCIQCWU2yqc2yDrtNgPimvLv/BniQ242gSbY5wHCpVrGMTMgIhANtvGSkv3tydnn8Nv9hWep7xx/jrWzAgtyjgGKxADyGd","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1984},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-4.0.0.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities in antibody sequences that may impact manufacturability, stability, or safety.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/7119150097b4882f4a3a5c2dab5fe5b8/platforma-open-milaboratories.antibody-sequence-liabilities-4.0.0.tgz","_integrity":"sha512-VEBQGyLKK4GIfddTAHl/jvFqr0o9iO3eOc4kIa7TyBjGxTRnWvPLTCgB5B1SDDCL303IEouRU+LEeF0p8VVGRg==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.1","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"5.0.0","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"5.0.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"5.0.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.7.0"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_4.0.0_1774546046320_0.3547816502057328","host":"s3://npm-registry-packages-npm-production"}},"4.0.1":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"4.0.1","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@4.0.1","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"844a1b5b22261dddcc1ff2c6f2b1f37665b16dcf","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-4.0.1.tgz","fileCount":1,"integrity":"sha512-FmUXt8CwclLTSCnhbcv9Z0j1bxh44G+UCkymYtT+x1El+1Myr/FZUCoCITJacL8GciOi6u5cE0nAR3KnnSKWgw==","signatures":[{"sig":"MEYCIQD/w6p4LbczoTITWf788fcARcENJLRgciNZl+x6RjK5xQIhAOQMqmrYPfsdIYp85tomMtSaoWj9M++spFoB8jcDKk70","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1984},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-4.0.1.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities in antibody sequences that may impact manufacturability, stability, or safety.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/98b758824a06c7aa00e0281c08437bf8/platforma-open-milaboratories.antibody-sequence-liabilities-4.0.1.tgz","_integrity":"sha512-FmUXt8CwclLTSCnhbcv9Z0j1bxh44G+UCkymYtT+x1El+1Myr/FZUCoCITJacL8GciOi6u5cE0nAR3KnnSKWgw==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.1","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"5.0.0","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"5.0.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"5.0.1"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.7.0"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_4.0.1_1774548003823_0.7758545035495763","host":"s3://npm-registry-packages-npm-production"}},"4.0.2":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"4.0.2","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@4.0.2","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"b219211e26a49fa6ed8c9c2d2be6b67600cb5e5a","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-4.0.2.tgz","fileCount":1,"integrity":"sha512-1UjarcWqIbl2PJFlxrzJ/glyjvNEbJmnqzKthd74mIcZNGHGxh+0/Han7AkZqqIWCHjkjEToubSdSLsoNlTVdg==","signatures":[{"sig":"MEUCIQDPVJ6+/2QCwtH5KTJpsa/4XgJ4xElL/denoZj36ySVpQIgf7DYBuXGyHrNA3IyKXUYv6YHqzHy8XozEsbPkZUrltk=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1984},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-4.0.2.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities in antibody sequences that may impact manufacturability, stability, or safety.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/102ece0008e2e9142842d5a4502da19a/platforma-open-milaboratories.antibody-sequence-liabilities-4.0.2.tgz","_integrity":"sha512-1UjarcWqIbl2PJFlxrzJ/glyjvNEbJmnqzKthd74mIcZNGHGxh+0/Han7AkZqqIWCHjkjEToubSdSLsoNlTVdg==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.1","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"5.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"5.0.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"5.0.1"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.7.0"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_4.0.2_1774643384018_0.7727928961460928","host":"s3://npm-registry-packages-npm-production"}},"4.0.3":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"4.0.3","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@4.0.3","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"dfc67e0f1e40aa9fe3761e5ffe05c59504cb76d0","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-4.0.3.tgz","fileCount":1,"integrity":"sha512-Y2jigA8VZn6eYJtoOLsisvEyo0YrasrXGk6k7CdlK1n8fbfcVe4+lGMvK0dTw+fgj29OnLfHc7BS43i43WhaUg==","signatures":[{"sig":"MEUCIQC+dXK8n1ZerrBcVqBVT6eXnM6RhtSURI16v6Lg/OBYugIgCE4ugMBmMQx6ExXjDer3wH/PNCzJLmkpWfqqsXdyY6M=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":1984},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-4.0.3.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","downstream"],"title":"Antibody Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities in antibody sequences that may impact manufacturability, stability, or safety.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/ada7e3e280617f59d1773429e62ac361/platforma-open-milaboratories.antibody-sequence-liabilities-4.0.3.tgz","_integrity":"sha512-Y2jigA8VZn6eYJtoOLsisvEyo0YrasrXGk6k7CdlK1n8fbfcVe4+lGMvK0dTw+fgj29OnLfHc7BS43i43WhaUg==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.1","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"5.1.0","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"5.1.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"5.1.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.7.5"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_4.0.3_1775231156856_0.0044619122416391654","host":"s3://npm-registry-packages-npm-production"}},"5.0.0":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.0.0","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.0.0","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"e65ae67644343261385bfe401d43e1631fd355bc","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.0.0.tgz","fileCount":1,"integrity":"sha512-fL87AQWEQE4p97PHSWVK28P+CCChPfi9OZGwRTRUHPJtnIDfhP8UZSyaxK/p43yjFSqr9/fxsg8qq5GAcTgDFQ==","signatures":[{"sig":"MEQCIDH+Zq7/tI2hrNPc3DyCrzCJICnnW/Gb1TKNWAo4EV9mAiAcCsnqGZtBEMrrzozp9WSW66RBzWNV2uxIaCBS1Axd9Q==","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":2010},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.0.0.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/42c3c5277382cce30c017daac71a9b57/platforma-open-milaboratories.antibody-sequence-liabilities-5.0.0.tgz","_integrity":"sha512-fL87AQWEQE4p97PHSWVK28P+CCChPfi9OZGwRTRUHPJtnIDfhP8UZSyaxK/p43yjFSqr9/fxsg8qq5GAcTgDFQ==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.0.0","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.0.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.0.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.7.18"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.0.0_1777581907590_0.9903891029502874","host":"s3://npm-registry-packages-npm-production"}},"5.0.1":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.0.1","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.0.1","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"f52809c3a2429f1a04263a1436be93fda72b75a6","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.0.1.tgz","fileCount":1,"integrity":"sha512-RJ2sRxqYQboReT7qArrmlM+FhrfwH5ZEQYpJCG53FMe2iSfoMXR4WmoAVTUDOAk8e7F/0PdokRnZ82gvlo0Qfg==","signatures":[{"sig":"MEUCIGfDK9IBoBSWme3VuOvx1urzKE0IbOX4AXWhIZueuuRdAiEA25LzMbZumlTRw66NJxPnOBrq52zH6v1mP+ocjUQrsbI=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":2010},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.0.1.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/1046fd78b3b44c3ebc38de2c1d603271/platforma-open-milaboratories.antibody-sequence-liabilities-5.0.1.tgz","_integrity":"sha512-RJ2sRxqYQboReT7qArrmlM+FhrfwH5ZEQYpJCG53FMe2iSfoMXR4WmoAVTUDOAk8e7F/0PdokRnZ82gvlo0Qfg==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.0.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.0.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.7.18"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.0.1_1778168803726_0.1614241476412388","host":"s3://npm-registry-packages-npm-production"}},"5.0.2":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.0.2","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.0.2","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"13a1d26aafe7f031acf4f8a2438fa341929d5282","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.0.2.tgz","fileCount":1,"integrity":"sha512-oIHuZvcRSUUrrqAiezr1nw7wUJT8IVTtuQaJUcQ7PrQlGrb/KEweNj3ZXw2m0z6nRwBmTbAkY8ktBSU+m7FIug==","signatures":[{"sig":"MEUCIGOSR9Uh0LrccHNMvdsXZtlNBdCLFuk5VV/xRXoByY4CAiEA8V+p+7HvkBCpEBsb34RBb2tER5YG8QSBSsj/khOjtPA=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":2010},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.0.2.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/1d1ddbba3886070f2af8fe24b95d279f/platforma-open-milaboratories.antibody-sequence-liabilities-5.0.2.tgz","_integrity":"sha512-oIHuZvcRSUUrrqAiezr1nw7wUJT8IVTtuQaJUcQ7PrQlGrb/KEweNj3ZXw2m0z6nRwBmTbAkY8ktBSU+m7FIug==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.0.2","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.0.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.7.23"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.0.2_1778232439621_0.34842750754081564","host":"s3://npm-registry-packages-npm-production"}},"5.0.3":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.0.3","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.0.3","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"2b1e0578ac9df8fce8e6ce64d2677b12dd0b39f3","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.0.3.tgz","fileCount":1,"integrity":"sha512-WEmje5+1mGUts78AR0ezgq2dKWYuJAhEe6CLI6eBmDNehrftzC4l1Fj/0sBZfvnP0FmavK9GccZ9AdDuSG2vsQ==","signatures":[{"sig":"MEUCIQDPU08/GrNCtce4jfthDyupG/kHy31PYEM48gNxyzF8/gIgCZTz7ikDtuK7IwYk3wAvxna0bH6b39iq0yf7UDzfgJk=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":2010},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.0.3.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/3be05f6d15f171b91191dd62135202a8/platforma-open-milaboratories.antibody-sequence-liabilities-5.0.3.tgz","_integrity":"sha512-WEmje5+1mGUts78AR0ezgq2dKWYuJAhEe6CLI6eBmDNehrftzC4l1Fj/0sBZfvnP0FmavK9GccZ9AdDuSG2vsQ==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.0.2","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.0.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.7.25"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.0.3_1779179945661_0.03966265628101873","host":"s3://npm-registry-packages-npm-production"}},"5.0.4":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.0.4","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.0.4","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"008ac2bda4440c51cacf591d19f9493299504830","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.0.4.tgz","fileCount":1,"integrity":"sha512-DBh7vVByRb0z9tiVGlu8mTLpfEiCGwTDQ029KgQfTY6DksHOEJ5koq+OBqBvW6IulZ2OW8WsAaO13P1xUM9RYA==","signatures":[{"sig":"MEYCIQDJRDQ/7Qv18m9veXl+SfWbqUoH8VCDriREeOuE4Xmh/QIhAJXmSjshJ6uw9m+HrAKMGylEMFK6G+KFN27T8PdIuBHN","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":2009},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.0.4.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/1761727f8088250399b4066beff9e955/platforma-open-milaboratories.antibody-sequence-liabilities-5.0.4.tgz","_integrity":"sha512-DBh7vVByRb0z9tiVGlu8mTLpfEiCGwTDQ029KgQfTY6DksHOEJ5koq+OBqBvW6IulZ2OW8WsAaO13P1xUM9RYA==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.0.2","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.0.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.8.3"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.0.4_1779753763821_0.9452536055242768","host":"s3://npm-registry-packages-npm-production"}},"5.0.5":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.0.5","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.0.5","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"257ebc52b9a8e1a5d6c923a534ec69fd880af0df","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.0.5.tgz","fileCount":1,"integrity":"sha512-FvuFx7RKx3B2AOvBZXbjNIpg87bdOMFr/mmoyXHjoCqS5IjkopS7iU2QDbtwLE0KdngEYpE+z63uYYFW1O7cPg==","signatures":[{"sig":"MEQCIGH6DXmxMmtnB+BM97od3NnbFp6xDiKQw+8zykOxrrnvAiBQFYDzucCWajT2im89BcDfzZd+HLWxwbfW40lDwtjJjQ==","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":2009},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.0.5.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/b293326f8aa597d353bccf525ae93ccd/platforma-open-milaboratories.antibody-sequence-liabilities-5.0.5.tgz","_integrity":"sha512-FvuFx7RKx3B2AOvBZXbjNIpg87bdOMFr/mmoyXHjoCqS5IjkopS7iU2QDbtwLE0KdngEYpE+z63uYYFW1O7cPg==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.0.2","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.0.1"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.8.3"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.0.5_1779802451675_0.36474190126311345","host":"s3://npm-registry-packages-npm-production"}},"5.0.6":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.0.6","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.0.6","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"73d7ee90dc1ca3da6af81f959122bbc007f18725","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.0.6.tgz","fileCount":1,"integrity":"sha512-o+WhUKXU4+23Sto4rmCiqsBlm3gy4Q1+yWl1rIIE8P+RQL3Wb2l/oTvH8yirB0HzhpI8NZ6xEytHJ9StgOOREg==","signatures":[{"sig":"MEQCICp5b8z+bkHkOeuD2xAXQLaXjSH3YQ78VdBm2yOI/FeIAiBedPeCyq2FsqtYTJJsXFeB3KuZRoWG7sVGksskkYAIcg==","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":2011},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.0.6.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/6513ffcb75a0fe7052391202ac735139/platforma-open-milaboratories.antibody-sequence-liabilities-5.0.6.tgz","_integrity":"sha512-o+WhUKXU4+23Sto4rmCiqsBlm3gy4Q1+yWl1rIIE8P+RQL3Wb2l/oTvH8yirB0HzhpI8NZ6xEytHJ9StgOOREg==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.0.2","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.0.2"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.10.15"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.0.6_1781696398360_0.6100415211510515","host":"s3://npm-registry-packages-npm-production"}},"5.0.7":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.0.7","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.0.7","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"c5a131e4ca4d64276b630045f5f569a999abf63a","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.0.7.tgz","fileCount":1,"integrity":"sha512-uB1Aokyvx6qQtG9QOEPNI4253NOB1XgeO947oVwXoZrY7La9T1cKyxsNOM1t8hirotu+BCMlKQjUzBtn/ts9pg==","signatures":[{"sig":"MEUCIHf2bCKrtpjPyH9EbXrPRMVS7/6w6s3a40ltp/rdAftKAiEAo16AaGRrWZPZULBj+TtBeZBhGG5Dri/K7c5RmvVfka4=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":2010},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.0.7.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/32ea33a501e6cd67b43f57d6c105f80b/platforma-open-milaboratories.antibody-sequence-liabilities-5.0.7.tgz","_integrity":"sha512-uB1Aokyvx6qQtG9QOEPNI4253NOB1XgeO947oVwXoZrY7La9T1cKyxsNOM1t8hirotu+BCMlKQjUzBtn/ts9pg==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.0.2","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.0.3"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.11.2"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.0.7_1782257301722_0.8583793648338967","host":"s3://npm-registry-packages-npm-production"}},"5.0.8":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.0.8","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.0.8","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"7bb51d8f8df6b7b6818e5869e117f83a4454bf5c","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.0.8.tgz","fileCount":1,"integrity":"sha512-NpK+1fNBzmbyOYdFgVlMA04Qko84ubgYtMYJcJcj1ucIe9jtwDnmkfPbAayhEkDfJE98y0aPy+zw0Z9dbFq2PQ==","signatures":[{"sig":"MEUCIQCFY7Mwkqbp0GXh2VpJoM9xwuDUANkzMrryGeXAM+kXnQIgIy22En4y+iAqR3qBOSxknxZc4AOnJhgXEksNNNXvfdE=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":2010},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.0.8.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/eac51e7344dac6916be2de5ed1cca133/platforma-open-milaboratories.antibody-sequence-liabilities-5.0.8.tgz","_integrity":"sha512-NpK+1fNBzmbyOYdFgVlMA04Qko84ubgYtMYJcJcj1ucIe9jtwDnmkfPbAayhEkDfJE98y0aPy+zw0Z9dbFq2PQ==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.0.2","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.0.4"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.11.2"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.0.8_1782260559150_0.9132261975578468","host":"s3://npm-registry-packages-npm-production"}},"5.0.9":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.0.9","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.0.9","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"ebc62abe8b7e6927529a0fe255a835af1d39c79c","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.0.9.tgz","fileCount":1,"integrity":"sha512-WiwM8mEzOtbLtVI0GyVO8Zwh7YX/KhY0cYl50lQCSzfgicXzj4NidLWhgma9QWgFAVeMuS3DhSxtzrR4K1u1WA==","signatures":[{"sig":"MEYCIQC/seSY7ztHpc4IYFh/fNZzDHPqQFdik5aYmsmPDIzx9wIhAKocXqJ2ZpFLL79eQZzuw7+gm5nMTR/fe11tft+xKvTX","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":2010},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.0.9.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/33c74e5bed1305edc2bf820207664196/platforma-open-milaboratories.antibody-sequence-liabilities-5.0.9.tgz","_integrity":"sha512-WiwM8mEzOtbLtVI0GyVO8Zwh7YX/KhY0cYl50lQCSzfgicXzj4NidLWhgma9QWgFAVeMuS3DhSxtzrR4K1u1WA==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.0.2","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.0.4"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.11.2"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.0.9_1782314716736_0.48283466880232995","host":"s3://npm-registry-packages-npm-production"}},"5.0.10":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.0.10","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.0.10","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"c082c35be80d67a174a485486c452949aaf966c1","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.0.10.tgz","fileCount":1,"integrity":"sha512-XrK1oN8fUrm4auZiWACLhsJJpxMQisd9VUe1T9HcuOmEq0QJnlw3Ixxd1f3rG2b6PdEw3dDx/KjNG4ZWcvn7Ew==","signatures":[{"sig":"MEUCIQCwaYb/K6MQHTCCpSxal8/+ZTzIMC3CgPta42CFQJjXHAIgCqMPPYU+2odqd/3NVahufsbFESyvVBRPSkKBUT6d9GA=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":2011},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.0.10.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/1aa8d1075e5e3d30b00467098af7d8a2/platforma-open-milaboratories.antibody-sequence-liabilities-5.0.10.tgz","_integrity":"sha512-XrK1oN8fUrm4auZiWACLhsJJpxMQisd9VUe1T9HcuOmEq0QJnlw3Ixxd1f3rG2b6PdEw3dDx/KjNG4ZWcvn7Ew==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.0.4","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.0.5"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.11.6"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.0.10_1782999119198_0.825257834576447","host":"s3://npm-registry-packages-npm-production"}},"5.0.11":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.0.11","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.0.11","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"61e4087c00c858bf6cbf5e347cd89df8639a9c2d","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.0.11.tgz","fileCount":1,"integrity":"sha512-JGjttBhtZXFVkqQFvdjcYBcYBk8zl9ejk45FElErD2WBgKc/A8uGLpVEi/UNmmxn+HZ551Oj64ausZs9Teeqtg==","signatures":[{"sig":"MEYCIQCGq4mWiEN8NZzR4hguYmAMrQY9VTZ61J68PJiGLjQpngIhAOfurczGSbHrtF+8bV7uq93/CcEXFQxNNnPQelKG/Gp5","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":2011},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.0.11.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/1a8e1d78c85cbf8d2e61be65d25a405f/platforma-open-milaboratories.antibody-sequence-liabilities-5.0.11.tgz","_integrity":"sha512-JGjttBhtZXFVkqQFvdjcYBcYBk8zl9ejk45FElErD2WBgKc/A8uGLpVEi/UNmmxn+HZ551Oj64ausZs9Teeqtg==","_npmVersion":"10.8.2","directories":{},"_nodeVersion":"20.20.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.0.4","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.0.3","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.0.6"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.12.6"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.0.11_1784044105002_0.6923026101084013","host":"s3://npm-registry-packages-npm-production"}},"5.1.0":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.1.0","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.1.0","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"8aceb72f5f37e5014452462d0fd30d604d1a0dc7","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.1.0.tgz","fileCount":1,"integrity":"sha512-D+NUfqmecqBfRgNEQufIPsbq2XZRzdGo/mcp+NCDYdlJJRWGHxfT5/L9DLLcyI7SEOj3RiKBoSw6MnHBLiHjxg==","signatures":[{"sig":"MEUCIQCsNUBwP6PpCI5k1qjrzPg2VSojd/wxlbBSbxFQE54kEQIgFkvYGP8EGhAUadIyRiGNGuguaS/dq6HrDIijqozmHvM=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":2010},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.1.0.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/04280c7c5f46425812adea7967873024/platforma-open-milaboratories.antibody-sequence-liabilities-5.1.0.tgz","_integrity":"sha512-D+NUfqmecqBfRgNEQufIPsbq2XZRzdGo/mcp+NCDYdlJJRWGHxfT5/L9DLLcyI7SEOj3RiKBoSw6MnHBLiHjxg==","_npmVersion":"10.9.8","directories":{},"_nodeVersion":"22.23.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.0.5","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.0.4","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.1.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.14.3"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.1.0_1787328489920_0.08599196563919387","host":"s3://npm-registry-packages-npm-production"}},"5.2.0":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.2.0","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.2.0","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"aa3d2575a06f71a61d0cc6593e98be8c270ebda5","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.2.0.tgz","fileCount":1,"integrity":"sha512-Vw6v/RA5kPeQFJN64fnwFE2ZiNJUVF1kjgFScbzw10AWBRve0vrc5WSTeX2ZDnsOhbZIBz3bFXouvEbisLX64w==","signatures":[{"sig":"MEUCIQDdk5JFXdUS3jLTrT2ICtn7NuCBTndjr5GmiCyh2FdJbwIgYS6+hhD9xAaL6DP1MV7NDJ5WbFZT6nvdm/QYS8Qr2Nc=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":2010},"_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.2.0.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"scripts":{"build":"shx rm -rf ./block-pack && block-tools pack","do-pack":"shx rm -f *.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/5bd3331d024532c7e5cbc4f62b4bd835/platforma-open-milaboratories.antibody-sequence-liabilities-5.2.0.tgz","_integrity":"sha512-Vw6v/RA5kPeQFJN64fnwFE2ZiNJUVF1kjgFScbzw10AWBRve0vrc5WSTeX2ZDnsOhbZIBz3bFXouvEbisLX64w==","_npmVersion":"10.9.8","directories":{},"_nodeVersion":"22.23.2","dependencies":{"@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.1.0","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.1.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.2.0"},"_hasShrinkwrap":false,"devDependencies":{"@platforma-sdk/block-tools":"2.14.3"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.2.0_1787649051801_0.14870254238506075","host":"s3://npm-registry-packages-npm-production"}},"5.2.1":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.2.1","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.2.1","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"27425100c77375846d924ebc238945432fbbf4f9","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.2.1.tgz","fileCount":18,"integrity":"sha512-hBz+xFggJ6n7FSNKU7xpH/ojfQXo8CxE1njt6bJWmR3KfXE/E2rhTci6IIt+b7THZAIfLHD84iOzAt0bAxIj2A==","signatures":[{"sig":"MEUCIQD7RGrLP71RCscex1dwRYPibQrZ5QNEdenyQbmJdIpabAIgQVQa2vDYxrG7NGUOiHVVVh5xNBCaJaCRky78fBlmdYk=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":7772724},"main":"./dist/index.js","type":"module","_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.2.1.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"types":"./dist/index.d.ts","module":"./dist/index.js","exports":{".":{"types":"./dist/index.d.ts","default":"./dist/index.js","sources":"./src/index.ts"}},"scripts":{"build":"ts-builder build --target block-facade && block-tools pack","check":"ts-builder type-check --target block-facade","do-pack":"shx rm -f package.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/f5305f48935dce4d340409e2c39ff1a6/platforma-open-milaboratories.antibody-sequence-liabilities-5.2.1.tgz","_integrity":"sha512-hBz+xFggJ6n7FSNKU7xpH/ojfQXo8CxE1njt6bJWmR3KfXE/E2rhTci6IIt+b7THZAIfLHD84iOzAt0bAxIj2A==","_npmVersion":"10.9.8","directories":{},"_nodeVersion":"22.23.2","dependencies":{},"_hasShrinkwrap":false,"devDependencies":{"shx":"^0.4.0","typescript":"~5.6.3","@platforma-sdk/model":"1.83.0","@milaboratories/ts-builder":"1.7.2","@milaboratories/ts-configs":"1.4.0","@platforma-sdk/block-tools":"2.14.3","@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.1.1","@platforma-open/milaboratories.antibody-sequence-liabilities.kind":"1.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.1.1","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.2.2"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.2.1_1788179051413_0.5753144092706979","host":"s3://npm-registry-packages-npm-production"}},"5.2.2":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.2.2","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.2.2","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"8bea69530f4c7c0b724e35454a7c9ad307e05f46","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.2.2.tgz","fileCount":18,"integrity":"sha512-uvGxr/qqfYpxuXC69Vv0oIA2WB0KSYrJQ8PQpNx8shkz5NbxcfmB8lwuYnYzkQIyxzUjotnzdpJ4R9t6scKsMQ==","signatures":[{"sig":"MEQCIHbAUdN3gleiTzgWK9+Nj9CbrtFYXovBaIRq7S53qXNrAiBftnpe+DFztUuxprfB4vybRVnPAzI6I1kCFHRUA+TXOg==","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":7772982},"main":"./dist/index.js","type":"module","_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.2.2.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"types":"./dist/index.d.ts","module":"./dist/index.js","exports":{".":{"types":"./dist/index.d.ts","default":"./dist/index.js","sources":"./src/index.ts"}},"scripts":{"build":"ts-builder build --target block-facade && block-tools pack","check":"ts-builder type-check --target block-facade","do-pack":"shx rm -f package.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/a2eeeef3b454b81105737691931af7b0/platforma-open-milaboratories.antibody-sequence-liabilities-5.2.2.tgz","_integrity":"sha512-uvGxr/qqfYpxuXC69Vv0oIA2WB0KSYrJQ8PQpNx8shkz5NbxcfmB8lwuYnYzkQIyxzUjotnzdpJ4R9t6scKsMQ==","_npmVersion":"10.9.8","directories":{},"_nodeVersion":"22.23.2","dependencies":{},"_hasShrinkwrap":false,"devDependencies":{"shx":"^0.4.0","typescript":"~5.6.3","@platforma-sdk/model":"1.83.0","@milaboratories/ts-builder":"1.7.2","@milaboratories/ts-configs":"1.4.0","@platforma-sdk/block-tools":"2.14.3","@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.1.1","@platforma-open/milaboratories.antibody-sequence-liabilities.kind":"1.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.1.1","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.2.4"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.2.2_1788789867605_0.8347437846799675","host":"s3://npm-registry-packages-npm-production"}},"5.3.0":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.3.0","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.3.0","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"07f4036a1e76d44a74fe07128bddc15a649619aa","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.3.0.tgz","fileCount":18,"integrity":"sha512-pgraiw6rUHpn3TLpcbhSo1CNdpt2GdOiNccHhdINn8+DffhrGnPEuUNqsyNq7lak93BlAgQzHKdjQZWKYhJBMg==","signatures":[{"sig":"MEUCIAze5VZ7KlXYzM9re5WomjeXe5n780pxtvTbuzrfnfVgAiEA6pkwGHCgOstlG0z8bPx0LqaNuNWfpcDZ4zpLPGAqWV4=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":7775488},"main":"./dist/index.js","type":"module","_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.3.0.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"types":"./dist/index.d.ts","module":"./dist/index.js","exports":{".":{"types":"./dist/index.d.ts","default":"./dist/index.js","sources":"./src/index.ts"}},"scripts":{"build":"ts-builder build --target block-facade && block-tools pack","check":"ts-builder type-check --target block-facade","do-pack":"shx rm -f package.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/d6651366f10f6bda49e08dce468f705e/platforma-open-milaboratories.antibody-sequence-liabilities-5.3.0.tgz","_integrity":"sha512-pgraiw6rUHpn3TLpcbhSo1CNdpt2GdOiNccHhdINn8+DffhrGnPEuUNqsyNq7lak93BlAgQzHKdjQZWKYhJBMg==","_npmVersion":"10.9.8","directories":{},"_nodeVersion":"22.23.2","dependencies":{},"_hasShrinkwrap":false,"devDependencies":{"shx":"^0.4.0","typescript":"~5.6.3","@platforma-sdk/model":"1.83.9","@milaboratories/ts-builder":"1.7.2","@milaboratories/ts-configs":"1.4.0","@platforma-sdk/block-tools":"2.15.0","@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.2.0","@platforma-open/milaboratories.antibody-sequence-liabilities.kind":"1.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.2.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.3.0"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.3.0_1788952620271_0.9205754968422211","host":"s3://npm-registry-packages-npm-production"}},"5.4.0":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.4.0","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.4.0","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"c06d81f03daecc015d809c303d392ddbd4f7ae69","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.4.0.tgz","fileCount":18,"integrity":"sha512-CENq+xLk3d84epJYSXL+9oTYA+dEhtvIJQQH0ppouvxUlQZbIcVFPw/pvczu5T9kT7VgAjzFeCoLrIyhi9qQ3g==","signatures":[{"sig":"MEQCIBRoVerwnvY69DEsS6yBhAVOKMlCEfZU/x5Xiy47hG2PAiBvOZOnVo6nct0mjYopYVo++2g3ms68IdxFour9967puA==","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"},{"sig":"MEQCIGhx7JIKf0ldM7v0y/9pqR0I3KsMMrK2X/2rDEWqa61wAiAN1VKWpQZe0IGqG48xhneQ1QJ+DXEusKgmf3+eFIBdpw==","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":7775582},"main":"./dist/index.js","type":"module","_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.4.0.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"types":"./dist/index.d.ts","module":"./dist/index.js","exports":{".":{"types":"./dist/index.d.ts","default":"./dist/index.js","sources":"./src/index.ts"}},"scripts":{"build":"ts-builder build --target block-facade && block-tools pack","check":"ts-builder type-check --target block-facade","do-pack":"shx rm -f package.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/b21f6d699addedf2b4ea8636cbd09d34/platforma-open-milaboratories.antibody-sequence-liabilities-5.4.0.tgz","_integrity":"sha512-CENq+xLk3d84epJYSXL+9oTYA+dEhtvIJQQH0ppouvxUlQZbIcVFPw/pvczu5T9kT7VgAjzFeCoLrIyhi9qQ3g==","_npmVersion":"10.9.8","directories":{},"_nodeVersion":"22.23.2","dependencies":{},"_hasShrinkwrap":false,"devDependencies":{"shx":"^0.4.0","typescript":"~5.6.3","@platforma-sdk/model":"1.83.9","@milaboratories/ts-builder":"1.7.2","@milaboratories/ts-configs":"1.4.0","@platforma-sdk/block-tools":"2.16.0","@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.2.0","@platforma-open/milaboratories.antibody-sequence-liabilities.kind":"1.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.2.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.4.0"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.4.0_1790071882122_0.6686703207122808","host":"s3://npm-registry-packages-npm-production"}},"5.4.1":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.4.1","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.4.1","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"b5b498dd90a1dcb167117a11d60cb4c7c05792a9","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.4.1.tgz","fileCount":18,"integrity":"sha512-XYNqXyeqW4KGT1oDEUxp0tYlsYJPWFh3xf9Oy2Wb+RSRcpz++f6dfvxJq8t4e0/D7P7ht2cOhgSn8CyX8slTvQ==","signatures":[{"sig":"MEUCIATvrOvYapCnyvw6AdXBYzSSJHfqTxIyh19S+aKhdWLCAiEA+oW/NgEqeCL6r7AvrFa3isCO3uA2geCTJYMRpYmRwbo=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"},{"sig":"MEUCIQCNsPgErgMZjtphifeeWn5LWLiSBtiENKUHI6Yxcaqs+gIgSPQwnIc9fcB8IsxgEYgr2J/q3IgOpZBoeHbMCij8G44=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":7804025},"main":"./dist/index.js","type":"module","_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.4.1.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"types":"./dist/index.d.ts","module":"./dist/index.js","exports":{".":{"types":"./dist/index.d.ts","default":"./dist/index.js","sources":"./src/index.ts"}},"scripts":{"build":"ts-builder build --target block-facade && block-tools pack","check":"ts-builder type-check --target block-facade","do-pack":"shx rm -f package.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/8eff370e6a8f1cc2be57cd408e24304d/platforma-open-milaboratories.antibody-sequence-liabilities-5.4.1.tgz","_integrity":"sha512-XYNqXyeqW4KGT1oDEUxp0tYlsYJPWFh3xf9Oy2Wb+RSRcpz++f6dfvxJq8t4e0/D7P7ht2cOhgSn8CyX8slTvQ==","_npmVersion":"10.9.8","directories":{},"_nodeVersion":"22.23.2","dependencies":{},"_hasShrinkwrap":false,"devDependencies":{"shx":"^0.4.0","typescript":"~5.6.3","@platforma-sdk/model":"1.83.17","@milaboratories/ts-builder":"1.7.2","@milaboratories/ts-configs":"1.4.0","@platforma-sdk/block-tools":"2.16.1","@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.2.0","@platforma-open/milaboratories.antibody-sequence-liabilities.kind":"1.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.2.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.5.0"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.4.1_1790092799860_0.34875153840979767","host":"s3://npm-registry-packages-npm-production"}},"5.4.2":{"name":"@platforma-open/milaboratories.antibody-sequence-liabilities","version":"5.4.2","_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.4.2","maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"dist":{"shasum":"a2d1fbd6cbd36d4a18e828fd55ca0ef919205226","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.4.2.tgz","fileCount":18,"integrity":"sha512-uPjtShipfZnpbUklOHNbzTs3bIFzQssM5AGuldvQLudXilivpWFHF2kgfRL7A11PlOdK89+14Ke8bjiuVb/GjQ==","signatures":[{"sig":"MEUCIQCpREEE7rwh677Hm8B5CzhEkE8hvbUc1CvdwsIvoacR/gIgKYn1P5sEg+74QhNbx1C4hfUvHQiPah/w8SAu9NL+TPg=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"},{"sig":"MEQCIDkus3Hdls+0IwVJk3KQpvlbRrnTs112tNSmPyXHXrrEAiA7t68LwLxZaROgB9mxsGcFbTBnP/1m5vEEaEmFY8eX7A==","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"}],"unpackedSize":7810156},"main":"./dist/index.js","type":"module","_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.4.2.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"types":"./dist/index.d.ts","module":"./dist/index.js","exports":{".":{"types":"./dist/index.d.ts","default":"./dist/index.js","sources":"./src/index.ts"}},"scripts":{"build":"ts-builder build --target block-facade && block-tools pack","check":"ts-builder type-check --target block-facade","do-pack":"shx rm -f package.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/69f4f6b1de8e2be0023914ecf7a1a8ec/platforma-open-milaboratories.antibody-sequence-liabilities-5.4.2.tgz","_integrity":"sha512-uPjtShipfZnpbUklOHNbzTs3bIFzQssM5AGuldvQLudXilivpWFHF2kgfRL7A11PlOdK89+14Ke8bjiuVb/GjQ==","_npmVersion":"10.9.9","directories":{},"_nodeVersion":"22.23.3","dependencies":{},"_hasShrinkwrap":false,"devDependencies":{"shx":"^0.4.0","typescript":"~5.6.3","@platforma-sdk/model":"1.84.1","@milaboratories/ts-builder":"1.7.2","@milaboratories/ts-configs":"1.4.0","@platforma-sdk/block-tools":"2.16.3","@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.2.0","@platforma-open/milaboratories.antibody-sequence-liabilities.kind":"1.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.2.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.5.0"},"_npmOperationalInternal":{"tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.4.2_1790672015328_0.949747790533594","host":"s3://npm-registry-packages-npm-production"}},"5.5.0":{"_id":"@platforma-open/milaboratories.antibody-sequence-liabilities@5.5.0","dist":{"shasum":"f67ebd572ac4f5c89bd98e456c46f97b464c5f75","tarball":"https://registry.npmjs.org/@platforma-open/milaboratories.antibody-sequence-liabilities/-/milaboratories.antibody-sequence-liabilities-5.5.0.tgz","fileCount":18,"integrity":"sha512-RG1LuRZr/Rpy7+T0cLUFdvLYyq4RPmig7qzN5q51iPu+DzoXAZqBThOG/dNz9rj5iD4/1kb+ekCGC8Zp+W3Zqg==","signatures":[{"sig":"MEUCIQDe7nU1Mgnv6FMjLSdAKStPc1yQ7G4R6ZhHJwxHtqnLnwIgVBHZlmkzcaJvK/rPxvvK20fL/MDbQQFA5LtRg31a7eA=","keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U"},{"keyid":"SHA256:DhQ8wR5APBvFHLF/+Tc+AYvPOdTpcIDqOhxsBHRwC7U","sig":"MEUCIHa4CEGzbHggng+wi+8KMisM2w3/mJaelILswws70TS5AiEAxHPbsv4HivKKbKbef40FdVKS5wuL8RS8f2d9JJBXlXE="}],"unpackedSize":7861417},"main":"./dist/index.js","name":"@platforma-open/milaboratories.antibody-sequence-liabilities","type":"module","_from":"file:platforma-open-milaboratories.antibody-sequence-liabilities-5.5.0.tgz","block":{"meta":{"url":"https://github.com/platforma-open/antibody-sequence-liabilities","docs":"https://docs.platforma.bio/guides/antibody-discovery/sequence-liabilities/","logo":"file:../logos/block-logo.png","tags":["airr","antibody","peptide","downstream"],"title":"Sequence Liabilities","support":"mailto:support@milaboratories.com","changelog":"file:../CHANGELOG.md","description":"Identifies sequence liabilities that may impact manufacturability, stability, or safety in antibody/TCR or peptide sequences.","organization":{"url":"https://milaboratories.com/","logo":"file:../logos/organization-logo.png","name":"MiLaboratories Inc"},"longDescription":"file:../docs/description.md","marketplaceRanking":15000},"components":{"ui":"@platforma-open/milaboratories.antibody-sequence-liabilities.ui/dist","model":"@platforma-open/milaboratories.antibody-sequence-liabilities.model/dist/model.json","workflow":"@platforma-open/milaboratories.antibody-sequence-liabilities.workflow/dist/tengo/tpl/main.plj.gz"}},"types":"./dist/index.d.ts","module":"./dist/index.js","exports":{".":{"types":"./dist/index.d.ts","default":"./dist/index.js","sources":"./src/index.ts"}},"scripts":{"build":"ts-builder build --target block-facade && block-tools pack","check":"ts-builder type-check --target block-facade","do-pack":"shx rm -f package.tgz && pnpm pack && shx mv *.tgz package.tgz","mark-stable":"block-tools mark-stable -r 's3://milab-euce1-prod-pkgs-s3-block-registry/pub/releases/?region=eu-central-1'"},"version":"5.5.0","_npmUser":{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},"_resolved":"/tmp/278a6b9e167d226271d5a1dbd58e6737/platforma-open-milaboratories.antibody-sequence-liabilities-5.5.0.tgz","_integrity":"sha512-RG1LuRZr/Rpy7+T0cLUFdvLYyq4RPmig7qzN5q51iPu+DzoXAZqBThOG/dNz9rj5iD4/1kb+ekCGC8Zp+W3Zqg==","_npmVersion":"10.9.9","directories":{},"maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"_nodeVersion":"22.23.3","dependencies":{},"_hasShrinkwrap":false,"devDependencies":{"shx":"^0.4.0","typescript":"~5.6.3","@platforma-sdk/model":"1.84.3","@milaboratories/ts-builder":"1.7.2","@milaboratories/ts-configs":"1.4.0","@platforma-sdk/block-tools":"2.16.5","@platforma-open/milaboratories.antibody-sequence-liabilities.ui":"6.3.0","@platforma-open/milaboratories.antibody-sequence-liabilities.kind":"1.0.1","@platforma-open/milaboratories.antibody-sequence-liabilities.model":"6.3.0","@platforma-open/milaboratories.antibody-sequence-liabilities.workflow":"6.6.0"},"_npmOperationalInternal":{"host":"s3://npm-registry-packages-npm-production","tmp":"tmp/milaboratories.antibody-sequence-liabilities_5.5.0_1790770897238_0.8355136099062495"}}},"time":{"created":"2025-04-17T12:45:35.587Z","modified":"2026-09-30T12:21:37.696Z","1.0.0":"2025-04-17T12:45:35.863Z","2.1.0":"2025-04-17T12:45:59.668Z","2.2.0":"2025-05-02T13:45:03.193Z","2.3.0":"2025-05-17T12:23:20.587Z","2.3.1":"2025-05-19T09:21:58.181Z","2.3.2":"2025-06-11T10:51:20.871Z","2.3.3":"2025-06-11T15:16:05.895Z","2.3.4":"2025-06-12T11:54:38.834Z","2.3.5":"2025-06-18T13:32:24.369Z","2.3.6":"2025-06-26T21:59:56.887Z","2.4.0":"2025-07-01T16:29:47.019Z","2.4.1":"2025-07-06T16:02:11.414Z","2.4.2":"2025-07-07T13:16:34.336Z","2.4.3":"2025-07-23T13:59:56.973Z","2.4.4":"2025-08-05T11:34:10.591Z","2.4.5":"2025-08-08T07:22:34.611Z","2.4.6":"2025-08-08T12:29:28.628Z","2.4.7":"2025-08-11T09:51:03.670Z","2.4.9":"2025-09-17T12:22:20.003Z","2.4.10":"2025-09-24T08:18:38.017Z","2.4.11":"2025-09-25T14:20:10.041Z","2.4.12":"2025-10-01T10:18:06.156Z","2.4.13":"2025-10-01T10:54:26.358Z","2.4.14":"2025-10-14T21:07:17.518Z","2.4.15":"2025-10-22T17:01:09.322Z","2.4.16":"2025-10-30T16:37:33.349Z","2.4.17":"2025-11-15T12:55:36.200Z","3.0.0":"2026-01-09T10:37:19.660Z","3.0.1":"2026-01-13T15:19:07.644Z","3.0.2":"2026-01-20T13:22:08.389Z","3.1.0":"2026-01-26T12:35:45.163Z","3.2.0":"2026-01-29T11:39:15.350Z","3.2.1":"2026-01-30T11:57:01.160Z","4.0.0":"2026-03-26T17:27:26.462Z","4.0.1":"2026-03-26T18:00:03.983Z","4.0.2":"2026-03-27T20:29:44.186Z","4.0.3":"2026-04-03T15:45:57.023Z","5.0.0":"2026-04-30T20:45:07.734Z","5.0.1":"2026-05-07T15:46:43.857Z","5.0.2":"2026-05-08T09:27:19.750Z","5.0.3":"2026-05-19T08:39:05.791Z","5.0.4":"2026-05-26T00:02:43.961Z","5.0.5":"2026-05-26T13:34:11.873Z","5.0.6":"2026-06-17T11:39:58.484Z","5.0.7":"2026-06-23T23:28:21.843Z","5.0.8":"2026-06-24T00:22:39.287Z","5.0.9":"2026-06-24T15:25:16.860Z","5.0.10":"2026-07-02T13:31:59.346Z","5.0.11":"2026-07-14T15:48:25.140Z","5.1.0":"2026-08-21T16:08:10.080Z","5.2.0":"2026-08-25T09:10:51.927Z","5.2.1":"2026-08-31T12:24:11.723Z","5.2.2":"2026-09-07T14:04:27.821Z","5.3.0":"2026-09-09T11:17:00.552Z","5.4.0":"2026-09-22T10:11:22.316Z","5.4.1":"2026-09-22T16:00:00.039Z","5.4.2":"2026-09-29T08:53:35.510Z","5.5.0":"2026-09-30T12:21:37.490Z"},"maintainers":[{"name":"mike-ainsel","email":"vladimir.antropov@milaboratories.com"},{"name":"dbolotin_mi","email":"bolotin@milaboratories.com"}],"readme":"ERROR: No README data found!","readmeFilename":""}